Cancer Research  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 1590-1595, April 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gamarra, F.
Right arrow Articles by Goetz, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gamarra, F.
Right arrow Articles by Goetz, A. E.

High-Energy Shock Waves Induce Blood Flow Reduction in Tumors1

Fernando Gamarra, Fritz Spelsberg, Gerhard E. H. Kuhnle and Alwin E. Goetz2

Institute of Surgical Research [F. G., F. S., G. E. H. K.] and Institute of Anesthesiology [A. E. G.], Ludwig-Maximilians-University Munich, Klinikum Grosshadern, Munich, Germany

We have studied the effect of extracorporeally applied high-energy shock waves (HESW) on blood flow in amelanotic melanomas (A-Mel-3). Two tumors were implanted in the dorsal skin of 21 Syrian golden hamsters. One of the tumors was treated with 200 HESW, and the other served as an intraindividual control. Mean blood flow in the whole tumor, or the tumor excluding necrotic areas, was quantitatively measured using autoradiography with iodo[14C]antipyrine at 30 min (n = 5), 1 h (n = 5), 3 h (n = 5), and 12 h (n = 6) after HESW treatment. As measured for the whole tumor, blood flow in the controls was 23.4 ± 7.9 ml/100 g/min (median ± SE) and thus in the range reported in the literature. Thirty min or 1 h after the application of HESW, tumor perfusion was reduced to 6 ± 4% or 5 ± 4% (median ± SE) of the corresponding controls, respectively. Three h after treatment, perfusion increased slightly to 7 ± 5% and after 12 h increased significantly to 55 ± 25% of the corresponding controls. Values measured excluding the necrotic areas were higher in all groups. Temporary reduction of tumor perfusion after treatment with HESW was interpreted as a consequence of HESW-induced damage to tumor microcirculation. These effects should be taken into account for maximizing the therapeutic efficiency of HESW on tumors and for combining HESW treatment with other therapeutical modalities.

1 Supported by grants of the Bundesministerium für Forschung und Technologie (0706903 A5) and the Kurt Körber Stiftung.

2 To whom requests for reprints should be addressed, at Institute of Anesthesiology, Klinikum Grosshadern, Ludwig-Maximilians-University, Marchioninistrasse 15, 8000 Munich 70, Germany.

Received 10/16/92. Accepted 1/25/93.




This article has been cited by other articles:


Home page
Cancer Res.Home page
P. E. Huber, J. W. Jenne, R. Rastert, I. Simiantonakis, H.-P. Sinn, H.-J. Strittmatter, D. von Fournier, M. F. Wannenmacher, and J. Debus
A New Noninvasive Approach in Breast Cancer Therapy Using Magnetic Resonance Imaging-guided Focused Ultrasound Surgery
Cancer Res., December 1, 2001; 61(23): 8441 - 8447.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.